Updated on 2025/03/08

写真a

 
Abe Yoshinori
 
Affiliation
Faculty of Medicine, Laboratory of Molecular Analysis, Senior Assistant Professor
Title
Senior Assistant Professor
External link

Degree

  • 博士(医学) ( 東京大学 )

Research Interests

  • シグナル伝達

  • Hedgehog

  • 癌幹細胞

  • 腫瘍

  • 慢性炎症

  • PRMT family

Research Areas

  • Life Science / Molecular biology

  • Life Science / Medical biochemistry

  • Life Science / Pathological biochemistry

Research History

  • Nippon Medical School   Laboratory of Molecular Analysis   Senior Assistant Professor

    2024.4

      More details

    Country:Japan

    researchmap

  • Nippon Medical School   Department of Molecular Oncology, Institute for Medical Sciences   Assistant Professor

    2003.4 - 2024.3

      More details

    Country:Japan

    researchmap

  • 日本学術振興会特別研究員(DC2)

    2001.4 - 2003.3

      More details

Professional Memberships

  • THE MOLECULAR BIOLOGY SOCIETY OF JAPAN

      More details

  • THE JAPANESE CANCER ASSOCIATION

      More details

Papers

  • PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth Reviewed

    Yoshinori Abe, Takumi Sano, Naoki Otsuka, Masashi Ogawa, Nobuyuki Tanaka

    Communications Biology   7 ( 1 )   2024.5

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    STAT3 is constitutively activated in many cancer types, including lung cancer, and can induce cancer cell proliferation and cancer stem cell (CSC) maintenance. STAT3 is activated by tyrosine kinases, such as JAK and SRC, but the mechanism by which STAT3 maintains its activated state in cancer cells remains unclear. Here, we show that PRMT5 directly methylates STAT3 and enhances its activated tyrosine phosphorylation in non-small cell lung cancer (NSCLC) cells. PRMT5 expression is also induced by STAT3, suggesting the presence of a positive feedback loop in cancer cells. Furthermore, methylation of STAT3 at arginine 609 by PRMT5 is important for its transcriptional activity and support of tumour growth and CSC maintenance. Indeed, NSCLC cells expressing the STAT3 mutant which R609 was replaced to alanine (R609K) show significantly impaired tumour growth in nude mice. Overall, our study reveals a mechanism by which STAT3 remains activated in NSCLC and provides a new target for cancer therapeutic approaches.

    DOI: 10.1038/s42003-024-06290-7

    researchmap

    Other Link: https://www.nature.com/articles/s42003-024-06290-7

  • The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target. Reviewed International journal

    Mamiko Tosa, Yoshinori Abe, Seiko Egawa, Tomoka Hatakeyama, Chihiro Iwaguro, Ryotaro Mitsugi, Ayaka Moriyama, Takumi Sano, Rei Ogawa, Nobuyuki Tanaka

    Communications biology   6 ( 1 )   1235 - 1235   2023.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Keloids are benign fibroproliferative skin tumors caused by aberrant wound healing that can negatively impact patient quality of life. The lack of animal models has limited research on pathogenesis or developing effective treatments, and the etiology of keloids remains unknown. Here, we found that the characteristics of stem-like cells from keloid lesions and the surrounding dermis differ from those of normal skin. Furthermore, the HEDGEHOG (HH) signal and its downstream transcription factor GLI1 were upregulated in keloid patient-derived stem-like cells. Inhibition of the HH-GLI1 pathway reduced the expression of genes involved in keloids and fibrosis-inducing cytokines, including osteopontin. Moreover, the HH signal inhibitor vismodegib reduced keloid reconstituted tumor size and keloid-related gene expression in nude mice and the collagen bundle and expression of cytokines characteristic for keloids in ex vivo culture of keloid tissues. These results implicate the HH-GLI1 pathway in keloid pathogenesis and suggest therapeutic targets of keloids.

    DOI: 10.1038/s42003-023-05561-z

    PubMed

    researchmap

  • Fine-Tuning of GLI Activity through Arginine Methylation: Its Mechanisms and Function Reviewed

    Yoshinori Abe, Nobuyuki Tanaka

    Cells   9 ( 9 )   1973 - 1973   2020.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    The glioma-associated oncogene (GLI) family consists of GLI1, GLI2, and GLI3 in mammals. This family has important roles in development and homeostasis. To achieve these roles, the GLI family has widespread outputs. GLI activity is therefore strictly regulated at multiple levels, including via post-translational modifications for context-dependent GLI target gene expression. The protein arginine methyl transferase (PRMT) family is also associated with embryogenesis, homeostasis, and cancer mainly via epigenetic modifications. In the PRMT family, PRMT1, PRMT5, and PRMT7 reportedly regulate GLI1 and GLI2 activity. PRMT1 methylates GLI1 to upregulate its activity and target gene expression. Cytoplasmic PRMT5 methylates GLI1 and promotes GLI1 protein stabilization. Conversely, nucleic PRMT5 interacts with MENIN to suppress growth arrest-specific protein 1 expression, which assists Hedgehog ligand binding to Patched, indirectly resulting in downregulated GLI1 activity. PRMT7-mediated GLI2 methylation upregulates its activity through the dissociation of GLI2 and Suppressor of Fused. Together, PRMT1, PRMT5, and PRMT7 regulate GLI activity at multiple revels. Furthermore, the GLI and PRMT families have strong links with various cancers through cancer stem cell maintenance. Therefore, PRMT-mediated regulation of GLI activity would have important roles in cancer stem cell maintenance.

    DOI: 10.3390/cells9091973

    researchmap

  • MEP50/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH/NUMB complex Reviewed

    Yoshinori Abe, Yosuke Suzuki, Kenji Kawamura, Nobuyuki Tanaka

    Communications Biology   2 ( 1 )   1 - 12   2019.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s42003-018-0275-4

    PubMed

    researchmap

  • Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2 Reviewed

    Yoshinori Abe, Eri Oda-Sato, Kei Tobiume, Keiko Kawauchi, Yoichi Taya, Koji Okamoto, Moshe Oren, Nobuyuki Tanaka

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   105 ( 12 )   4838 - 4843   2008.3

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATL ACAD SCIENCES  

    The hedgehog (Hh) signaling pathway regulates the development of many organs in mammals, and activation of this pathway is widely observed in human cancers. Although it is known that Hh signaling activates the expression of genes involved in cell growth, the precise role of the Hh pathway in cancer development is still unclear. Here, we show that constitutively activated mutants of Smoothened (Smo), a transducer of the Hh signaling pathway, inhibit the accumulation of the tumor suppressor protein p53. This inhibition was also observed in the presence of Hh ligand or with the overexpression of the transcription factors Gli1 and Gli2, downstream effectors of Smo, indicating that this inhibition is specific for the Hh pathway. We also report that Smo mutants augment p53 binding to the E3 ubiquitin-protein ligase Mdm2 and promote p53 ubiquitination. Furthermore, Hh signaling induced the phosphorylation of human Mdm2 protein on serines 166 and 186, which are activating phosphorylation sites of Mdm2. Smo mutants enhanced the proliferation of mouse embryonic fibroblasts (MEFs) while inducing a DNA-damage response. Moreover, Smo partially inhibited p53-dependent apoptosis and cell growth inhibition in oncogene-expressing MEFs. We also found that accumulation of p53 is inhibited by Hh signaling in several human cancer cell lines. Therefore, the Hh pathway may be a powerful accelerator of oncogenesis by activating cell proliferation and inhibiting the p53-mediated anti-cancer barrier induced by oncogenic stress.

    DOI: 10.1073/pnas.0712216105

    Web of Science

    researchmap

  • The Role of PRMT5 in Immuno-Oncology Reviewed

    Yoshinori Abe, Takumi Sano, Nobuyuki Tanaka

    Genes   14 ( 3 )   678 - 678   2023.3

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Immune checkpoint inhibitor (ICI) therapy has caused a paradigm shift in cancer therapeutic strategy. However, this therapy only benefits a subset of patients. The difference in responses to ICIs is believed to be dependent on cancer type and its tumor microenvironment (TME). The TME is favorable for cancer progression and metastasis and can also help cancer cells to evade immune attacks. To improve the response to ICIs, it is crucial to understand the mechanism of how the TME is maintained. Protein arginine methyltransferase 5 (PRMT5) di-methylates arginine residues in its substrates and has essential roles in the epigenetic regulation of gene expression, signal transduction, and the fidelity of mRNA splicing. Through these functions, PRMT5 can support cancer cell immune evasion. PRMT5 is necessary for regulatory T cell (Treg) functions and promotes cancer stemness and the epithelial–mesenchymal transition. Specific factors in the TME can help recruit Tregs, tumor-associated macrophages, and myeloid-derived suppressor cells into tumors. In addition, PRMT5 suppresses antigen presentation and the production of interferon and chemokines, which are necessary to recruit T cells into tumors. Overall, PRMT5 supports an immunosuppressive TME. Therefore, PRMT5 inhibition would help recover the immune cycle and enable the immune system-mediated elimination of cancer cells.

    DOI: 10.3390/genes14030678

    researchmap

  • Statins Show Anti-Atherosclerotic Effects by Improving Endothelial Cell Function in a Kawasaki Disease-Like Vasculitis Mouse Model Reviewed International journal

    Yusuke Motoji, Ryuji Fukazawa, Ryosuke Matsui, Yoshinori Abe, Ikuno Uehara, Makoto Watanabe, Yoshiaki Hashimoto, Yasuo Miyagi, Noriko Nagi-Miura, Nobuyuki Tanaka, Yosuke Ishii

    International Journal of Molecular Sciences   23 ( 24 )   16108 - 16108   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Kawasaki disease (KD) is an acute inflammatory syndrome of unknown etiology that is complicated by cardiovascular sequelae. Chronic inflammation (vasculitis) due to KD might cause vascular cellular senescence and vascular endothelial cell damage, and is a potential cause of atherosclerosis in young adults. This study examined the effect of KD and HMG-CoA inhibitors (statins) on vascular cellular senescence and vascular endothelial cells. Candida albicans water-soluble fraction (CAWS) was administered intraperitoneally to 5-week-old male apolipoprotein E-deficient (Apo E-/-) mice to induce KD-like vasculitis. The mice were then divided into three groups: control, CAWS, and CAWS+statin groups. Ten weeks after injection, the mice were sacrificed and whole aortic tissue specimens were collected. Endothelial nitric oxide synthase (eNOS) expression in the ascending aortic intima epithelium was evaluated using immunostaining. In addition, eNOS expression and levels of cellular senescence markers were measured in RNA and proteins extracted from whole aortic tissue. KD-like vasculitis impaired vascular endothelial cells that produce eNOS, which maintains vascular homeostasis, and promoted macrophage infiltration into the tissue. Statins also restored vascular endothelial cell function by promoting eNOS expression. Statins may be used to prevent secondary cardiovascular events during the chronic phase of KD.

    DOI: 10.3390/ijms232416108

    PubMed

    researchmap

  • Effect of Remifentanil-Based Anesthesia on Perioperative Phagocytic Function of Human Monocytes Reviewed

    Manzo Suzuki, Yoshinori Abe, Yusuke Taguchi, Hiroyasu Bito

    BPB Reports   3 ( 1 )   45 - 49   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients Reviewed

    Wataru Sugimoto, Katsuhiko Ito, Hiroaki Hirata, Yoshinori Abe, Takeru Torii, Yasumasa Mitsui, Yemima Budirahardja, Nobuyuki Tanaka, Keiko Kawauchi

    Bioengineering   7 ( 18 )   1 - 12   2020.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3390/bioengineering7010018

    researchmap

  • Roles of the Hedgehog signaling pathway in epidermal and hair follicle development, homeostasis, and cancer Reviewed

    Yoshinori Abe, Nobuyuki Tanaka

    Journal of Developmental Biology   5 ( 4 )   2017.12

     More details

    Authorship:Lead author   Language:English   Publisher:MDPI Multidisciplinary Digital Publishing Institute  

    The epidermis is the outermost layer of the skin and provides a protective barrier against environmental insults. It is a rapidly-renewing tissue undergoing constant regeneration, maintained by several types of stem cells. The Hedgehog (HH) signaling pathway is one of the fundamental signaling pathways that contributes to epidermal development, homeostasis, and repair, as well as to hair follicle development and follicle bulge stem cell maintenance. The HH pathway interacts with other signal transduction pathways, including those activated by Wnt, bone morphogenetic protein, platelet-derived growth factor, Notch, and ectodysplasin. Furthermore, aberrant activation of HH signaling is associated with various tumors, including basal cell carcinoma. Therefore, an understanding of the regulatory mechanisms of the HH signaling pathway is important for elucidating fundamental mechanisms underlying both organogenesis and carcinogenesis. In this review, we discuss the role of the HH signaling pathway in the development and homeostasis epidermis and hair follicles, and in basal cell carcinoma formation, providing an update of current knowledge in this field.

    DOI: 10.3390/jdb5040012

    Scopus

    researchmap

    Other Link: http://orcid.org/0000-0003-3894-494X

  • The Hedgehog Signaling Networks in Lung Cancer: The Mechanisms and Roles in Tumor Progression and Implications for Cancer Therapy Reviewed

    Yoshinori Abe, Nobuyuki Tanaka

    BIOMED RESEARCH INTERNATIONAL   2016   1   2016

     More details

    Authorship:Lead author   Language:English   Publisher:HINDAWI LTD  

    Lung cancer is the most common cause of cancer-related death worldwide and is classified into small cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). Several gene mutations that contribute to aberrant cell proliferation have been identified in lung adenocarcinoma, a part of NSCLC. Various anticancer drugs that target these mutated molecules have been developed for NSCLC treatment. However, although molecularly targeted drugs are initially effective for patients, the 5-year survival rate remains low because of tumor relapse. Therefore, more effective drugs for lung cancer treatment should be developed. The hedgehog (HH) signaling pathway contributes to organ development and stem cell maintenance, and aberrant activation of this signaling pathway is observed in various cancers including lung cancer. In lung cancer, HH signaling pathway upregulates cancer cell proliferation and maintains cancer stem cells as well as cancer-associated fibroblasts (CAFs). Furthermore, physical contact between CAFs and NSCLC cells induces HH signaling pathway activation in NSCLC cells to enhance their metastatic potential. Therefore, HH signaling pathway inhibitors could be a useful option for lung cancer therapy.

    DOI: 10.1155/2016/7969286

    Web of Science

    researchmap

  • Coronin7 forms a novel E3 ubiquitin ligase complex to promote the degradation of the anti-proliferative protein Tob Reviewed

    Makoto Watanabe, Toru Suzuki, Minsoo Kim, Yoshinori Abe, Yutaka Yoshida, Sumio Sugano, Tadashi Yamamoto

    FEBS LETTERS   585 ( 1 )   65 - 70   2011.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    Tob belongs to the anti-proliferative Tob/BTG family. The level of Tob throughout the cell cycle is regulated by the SCF (Skp1/Cullin/F-box protein) Skp2 ubiquitin ligase (E3) complex. Here, we show that Coronin7 (CRN7) is also involved in Tob degradation. We identified CRN7 as a Tob-interacting molecule. A sequence containing two of the six WD motifs in the middle of CRN7 was responsible for the interaction. CRN7 enhanced the polyubiquitination of Tob in vitro, and overexpression of CRN7 promoted proteasome-dependent degradation of Tob. Furthermore, CRN7 interacted with Cullin1 and Roc1 to form a novel SCF-like E3 complex, suggesting that Tob protein is regulated by multiple ubiquitination machineries.
    Structured summary:
    Cullin1 physically interacts with CRN7:shown by anti tag coimmunoprecipitation (view interaction)
    Roc1 physically interacts with CRN7:shown by anti tag coimmunoprecipitation (view interaction)
    CRN7 physically interacts with Tob1:shown by anti tag coimmunoprecipitation (view interaction)
    CDC34 physically interacts with CRN7:shown by anti tag coimmunoprecipitation (view interaction)
    Tob1 and CRN7 colocalize:shown by fluorescence microscopy (view interaction)
    Elongin B physically interacts with CRN7:shown by anti tag coimmunoprecipitation (view interaction)
    Elongin C physically interacts with CRN7:shown by anti tag coimmunoprecipitation (view interaction)
    Tob1 physically interacts with CRN7:shown by two hybrid (view interaction) (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.

    DOI: 10.1016/j.febslet.2010.11.049

    Web of Science

    researchmap

  • Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 Reviewed

    Masaru Ando, Lkuno Uehara, Kayo Kogure, Yumi Asano, Wataru Nakajima, Yoshinori Abe, Keiko Kawauchi, Nobuyuki Tanaka

    Journal of Nippon Medical School   77 ( 2 )   97 - 105   2010.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Enhanced glycolysis is important for oncogenesis and for the survival and proliferation of cancer cells in the tumor microenvironment. Recent studies have also shown that proinflammatory cytokine signaling, such as that mediated by nuclear factor κB and signal transducer and activator of transcription 3 (STAT3), is important for the generation of inflammation-associated tumors. However, the link between inflammation and enhanced glycolysis has not been identified. In the present study, we found that the proinflammatory cytokine interleukin (IL)-6 enhanced glycolysis in mouse embryonic fibroblasts and human cell lines. Moreover, STAT3 activated by IL-6 enhanced the expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6- bisphosphatase-3 (PFKFB3). Ectopic expression of PFKFB3 enhanced glycolysis, suggesting that the IL-6-STAT3 pathway enhances glycolysis through the induction of these enzymes. Our findings may provide a novel mechanism for inflammation-associated oncogenesis.

    DOI: 10.1272/jnms.77.97

    Scopus

    PubMed

    researchmap

  • Hedgehogシグナル伝達経路活性化によるユビキチン化を介したp53の分解亢進の意義 Reviewed

    生体の科学   2009.12

     More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.11477/mf.2425100944

    researchmap

  • Faculty of 1000 evaluation for Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2. Reviewed

    W Brent Derry

    F1000 - Post-publication peer review of the biomedical literature   2008.5

     More details

    Publisher:Faculty of 1000, Ltd.  

    DOI: 10.3410/f.1109006.566173

    researchmap

  • Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3 beta-mediated phosphorylation of beta-catenin Reviewed

    K. Haraguchi, M. Ohsugi, Y. Abe, K. Semba, T. Akiyama, T. Yamamoto

    ONCOGENE   27 ( 3 )   274 - 284   2008.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    The Wnt signaling pathway is essential for embryonic development and carcinogenesis. Upon Wnt stimulation, beta-catenin is stabilized and associates with T-cell factor or lymphoid enhancing factor, thereby activating transcription of target genes. In the absence of Wnt stimulation, the level of beta-catenin is reduced via glycogen synthase kinase (GSK)-beta b-mediated phosphorylation and subsequent proteasome-dependent degradation. Here, we report the identification of Ajuba as a negative regulator of the Wnt signaling pathway. Ajuba is a member of LIM domain-containing proteins that contribute to cell fate determination and regulate cell proliferation and differentiation. We found that enforced expression of Ajuba destabilized beta-catenin and suppressed target gene expression. Ajuba promoted GSK-3 beta-mediated phosphorylation of beta-catenin by reinforcing the association between beta-catenin and GSK-3 beta. Furthermore, Wnt stimulation induced both accumulation of beta-catenin and destabilization of Ajuba. Our findings suggest that Ajuba is important for regulation of the Wnt signaling pathway.

    DOI: 10.1038/sj.onc.1210644

    Web of Science

    researchmap

  • ZRP-1 controls Rho GTPase-mediated actin reorganization by localizing at cell-matrix and cell-cell adhesions Reviewed

    Chen-Yu Bai, Miho Ohsugi, Yoshinori Abe, Tadashi Yamamoto

    JOURNAL OF CELL SCIENCE   120 ( 16 )   2828 - 2837   2007.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:COMPANY OF BIOLOGISTS LTD  

    Focal adhesion protein ZRP-1/TRIP6 has been implicated in actin reorganization and cell motility. The role of ZRP-1, however, remained obscure because previously reported data are often conflicting one another. In the present study, we examined roles of ZRP-1 in HeLa cells. ZRP-1 is localized to the cell-cell contact sites as well as to cell-matrix contact sites in HeLa cells. RNA-interference-mediated depletion of ZRP-1 from HeLa cells revealed that ZRP-1 is essential not only for the formation of stress fibers and assembly of mature focal adhesions, but also for the actin reorganization at cell-cell contact sites and for correct cell-cell adhesion and, thus, for collective cell migration. Impairment of focal adhesions and stress fibers caused by ZRP-1 depletion has been associated with reduced tyrosine phosphorylation of FAK. However, maturation of focal adhesions could not be recovered by expression of active FAK. Interestingly, stress fibers in ZRP-1-depleted cells were ameliorated by exogenous expression of RhoA. We also found that total Rac1 activity is elevated in ZRP-1-depleted cells, resulting in abnormal burst of actin polymerization and dynamic membrane protrusions. Taken together, we conclude that that ZRP-1 plays a crucial role in coupling the cell-matrix/cell-cell-contact signals with Rho GTPase-mediated actin remodeling by localizing at cell-matrix and cell-cell contact sites.

    DOI: 10.1242/jcs.03477

    Web of Science

    researchmap

  • The negative regulation of p53 by hedgehog signaling Reviewed

    Abe Yoshinori, Oda-Sato Eri, Tobiume Kei, Kawauchi Keiko, Okamoto Koji, Taya Yoichi, Tanaka Nobuyuki

    CANCER RESEARCH   66 ( 8 )   2006.4

     More details

    Authorship:Lead author   Language:English   Publisher:AMER ASSOC CANCER RESEARCH  

    Web of Science

    researchmap

  • LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis Reviewed

    Y Abe, M Ohsugi, K Haraguchi, J Fujimoto, T Yamamoto

    FEBS LETTERS   580 ( 3 )   782 - 788   2006.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    LATS2 is a human homolog of Drosaphila tumor suppressor lats/warts, and encodes a mitotic kinase whose physiological roles remain to be elucidated. We performed yeast two-hybrid screening and identified a LIM protein Ajuba, as a binding partner of LATS2. LATS2 was localized to the centrosomes throughout the cell cycle and was associated with Ajuba during mitosis, contributing to latter's mitotic phosphorylation. Depletion of LATS2 or Ajuba impaired centrosomal accumulation of gamma-tubulin and spindle formation at the onset of mitosis, suggesting that the LATS2-Ajuba complex regulates organization of the spindle apparatus through recruitment of gamma-tubulin to the centrosome. (c) 2006 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.

    DOI: 10.1016/j.febslet.2005.12.096

    Web of Science

    researchmap

  • Characterization of an apoptosis-inducing factor in Habu snake venom as a glycyrrhizin (GL)-binding protein potently inhibited by GL in vitro Reviewed

    Y Abe, Y Shimoyama, H Munakata, J Ito, N Nagata, K Ohtsuki

    BIOLOGICAL & PHARMACEUTICAL BULLETIN   21 ( 9 )   924 - 927   1998.9

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

    By means of successive heparin-affinity and glycyrrhizin (GL)-affinity column chromatographies (HPLC), a 55 kDa GL-binding protein (gp55) was purified to apparent homogeneity from the Superdex P-I fraction of Habu snake venom. This gp55 was identified as an apoxin I-like protein, because (i) its 20 N-terminal amino acid residues (AHDRNPLEEYFRETDYEEFL) are 95% identical with the corresponding sequence of apoxin I (apoptosis-inducing factor, approx. 55 kDa) in the venom of the western diamondback rattlesnake; and (ii) L-amino acid oxidase (LAO) activity of gp55 is detected when incubated with L-leucine, but not with D-leucine. GL inhibited the LAO activity of gp55 in a dose-dependent manner, but had no effect on the activity of a 65 kDa LAO also purified from Habit snake venom. In addition, GL reduced the ability of gp55 to induce the hemolysis of sheep red blood cells. These results suggest that GL is a potent inhibitor of apoxin I-like proteins in harmful snake venoms.

    DOI: 10.1248/bpb.21.924

    Web of Science

    researchmap

  • Separation of phospholipase A(2) in Habu snake venom by glycyrrhizin (GL)-affinity column chromatography and identification of a GL-sensitive enzyme Reviewed

    K Ohtsuki, Y Abe, Y Shimoyama, T Furuya, H Munakata, C Takasaki

    BIOLOGICAL & PHARMACEUTICAL BULLETIN   21 ( 6 )   574 - 578   1998.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PHARMACEUTICAL SOC JAPAN  

    By means of glycyrrhizin (GL)-affinity and Mono S column chromatographies (HPLC), at least four GL-binding proteins (p25, p17, p15-1 and p15-2) in the two Superdex fractions (P-II and P-III fractions) from Habu snake venom were selectively purified, Bg determination of their N-terminal partial amino acid sequences, a metalloprotease (p25) and three GL-binding phospholipases Az (gbPLA(2)s) [PA2Y (p17), PA21 (p15-1) and PA2B (p15-2)] were identified. PA2B (lysine-49 PLA(2)) was found to be the most sensitive to GL because (i) it strongly bound to a GL-affinity column; and (ii) its enzyme activity was selectively inhibited by low dose (ID50=approx. 1.5 mu M) of GL, hut not by GA. Furthermore, these three gbPLA(2)s were phosphorylated by casein kinase II (CK-II) in vitro and GL inhibited the CK-II-mediated stimulation of their enzyme activities in vitro.

    DOI: 10.1248/bpb.21.574

    Web of Science

    researchmap

▼display all

Misc.

▼display all

Industrial property rights

  • 肺癌治療のための抗癌剤の効果の検査法

    阿部芳憲

     More details

    Application no:特願2016-094888  Date applied:2016.5

    Announcement no:特開2017-201920  Date announced:2017.11

    Patent/Registration no:特許6789512  Date registered:2020.11 

    Rights holder:阿部芳憲, 田中信之

    researchmap

Awards

  • 日本医科大学賞 (研究部門)

    2009.3   日本医科大学  

    阿部芳憲

     More details

Research Projects

  • Analysis of arginine methylation signal network in pancreatic cancer to develop the novel cancer therapeutic strategy

    Grant number:23K06641  2023.4 - 2026.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research (C)  Scientific Research (C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    researchmap

  • 空間的な遺伝子解析によるケロイド発生機序の解明と新規治療標的の導出

    Grant number:23K09106  2023.4 - 2026.3

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    土佐 眞美子, 阿部芳憲

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    researchmap

  • アルギニンメチル基転移酵素PRMT5による膵臓癌発症を制御する分子機構の解明

    Grant number:2012  2022.4 - 2025.3

    東京大学医科学研究所  共同利用・共同研究拠点事業 

    阿部芳憲, 佐野匠, 小川容史

      More details

    Authorship:Principal investigator 

    researchmap

  • .

    Grant number:21nk0101572h0002  2021.10 - 2026.3

    Japan Agency for Medical Research and Development 

    Yoshinori Abe

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\30000000 ( Direct Cost: \27000000 、 Indirect Cost:\3000000 )

    researchmap

  • PRMT5による新たなケロイド幹細胞制御機構の解明と新治療薬開発への挑戦

    Grant number:20K09855  2020.4 - 2023.3

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    土佐 眞美子, 阿部芳憲

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

    ケロイドは、ヒト特有の疾患であるために原因解明には至っていない。、そのため、特効薬の開発は困難で、臨床現場では、対処療法がメインとなっているのが現状である。今までのケロイド研究は、ケロイド由来の線維芽細胞を用いたものががほとんどであった。われわれは、ケロイド組織例の約10%に異所性骨化を認めることを見出し、正常皮膚には存在しないはずの細胞がケロイド内に存在するのではないかと考えた、その起源として、組織異常幹細胞(ケロイド真皮幹細胞)に着目した。これまでに、得られた予備知見として、ケロイド患者では、ケロイド真皮 由来幹細胞におけるPRMT5発現が亢進しており、それは、第一世代のPRMT5阻害薬により、抑制されたことがあげられる。ケロイド真皮由来幹細胞やケロイド組織 におけるPRMT5タンパク発現の亢進のとケロイド組織を用いてPRMT5の免疫組織学的染色を行い、その発現分布を確認して、それぞれ、正常皮膚との比較を行った。 現在、ケロイド真皮由来幹細胞においてPRMT5がどのような遺伝子群を制御しているのかを明らかにするために、KSにiRNAを安定発現させてPRMT5発現を抑制後、細胞から、RNAを抽出して、多角的に発現解析を行い、PRMT5が発現制御する遺伝子群の役割をpathway解析ソフトを用いて、発現2倍以上でp値の低い順にPRMT5標的遺伝子を絞り込み、その結果の検証作業に入っている。

    researchmap

  • Analysis of the mechanism of PRMT5-mediated pancreatic cancer stem cells maintenance, and development of therapeutic strategy targeting pancreatic cancer stem cells by PRMT5 inhibition

    Grant number:20K09044  2020.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    researchmap

  • Establishment of therapeutic strategy for KRAS-mutant cancer targeting PRMT5-mediated cancer stem cells maintenance machinery

    2020.3 - 2021.3

    Hitachi Foundation 

    Yoshinori Abe

      More details

    Authorship:Principal investigator 

    researchmap

  • .

    2020.1 - 2020.12

    Japan Agency for Medical Research and Development 

    Yoshinori Abe

      More details

    Authorship:Principal investigator 

    Grant amount:\5070000

    researchmap

  • Elucidation of maintenance mechanism of mesenchymal stem cells in keloid to develop new therapy

    Grant number:17K11557  2017.4 - 2020.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)  Grant-in-Aid for Scientific Research (C)

    Tosa Mamiko

      More details

    Grant amount:\4810000 ( Direct Cost: \3700000 、 Indirect Cost:\1110000 )

    Fibroblasts and stem cells were cultured from (1) redness and (2) ridges (3) normal dermis of keloid patients, and (4) dermis-derived fibroblasts and stem cells of healthy individuals without keloid were used as controls. The A gene was highly expressed in (1), (2), and (3), and when the inhibitor X of the A gene was allowed to act on the cells, a concentration-dependent inhibitory effect was confirmed only in keloid-derived stem cells. These results suggest that gene A is involved in keloid development and that its inhibitor X may be a new therapeutic agent for keloids. In the future, we will analyze other genes related to gene A and aim to establish a more effective external drug for keloid treatment with few side effects.

    researchmap

  • The novel mechanisms of sonic hedgehog gene expression in the chronic inflammation induced cancer

    Grant number:25870792  2013.4 - 2016.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    Abe Yoshinori

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\3120000 ( Direct Cost: \2400000 、 Indirect Cost:\720000 )

    Lung cancer is the most leading cause of cancer death. We found that the expression of sonic hedgehog (Shh) gene, which is a ligand required for hedgehog signaling pathway activation was enhanced in lung cancer-derived cell lines.
    From subsequent analysis, we found that a transcription factor STAT3, which is involved in the chronic inflammation-induced tumorigenesis, induced Shh gene expression in lung cancer-derived cell lines. This mechanism may play an important role in tumor maintenance.

    researchmap

  • がん化に関わる全く新しい細胞増殖シグナル伝達機構の解析(STAT3-MEP50を介した Gli1 活性化経路の細胞のがん化機構)

    2013.4 - 2014.3

    日本私学振興・共済事業団  学術研究振興資金 

    阿部芳憲

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • がん化に関わる全く新しい細胞増殖シグナル伝達機構の解析(STAT3-MEP50を介した Gli1 活性化経路の細胞のがん化機構)

    2013.4 - 2014.3

    日本医科大学  日本医科大学若手研究奨励費 

    阿部芳憲

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 癌化に関わる STAT3を介した新しい Hedgehog 経路活性化機構の解析

    2012.9 - 2013.3

    日本医科大学  日本医科大学若手研究奨励費 

    阿部芳憲

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 新規 Hedgehog シグナル伝達経路制御分子機構の解明

    2009.4 - 2010.3

    日本医科大学  日本医科大学賞(研究部門) 研究助成金 

    阿部芳憲

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • 新規 Hedgehog シグナル伝達経路制御分子機構の解明

    2008.6 - 2009.3

    横浜学術振興財団  研究助成 

    阿部芳憲

      More details

    Authorship:Principal investigator  Grant type:Competitive

    researchmap

  • Analysis of the gene transcriptional network system regulated by nuclear tumor suppressive factors

    Grant number:17054039  2005 - 2009

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Priority Areas  Grant-in-Aid for Scientific Research on Priority Areas

    TANAKA Nobuyuki, ABE Yoshinori, UEHARA Ikuno, NAKAJIMA Wataru, SATO Eri, KAWAUTI Keiko, TOBIUME Kei

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\86000000 ( Direct Cost: \86000000 )

    Cancer cells preferentially utilize aerobic glycolysis for energy provision and this metabolic change is important for tumour growth. In this study period, we found that tumor suppressor p53 limits glycolysis. and that loss of function of p53 induces enhancement of glycolysis through activation of the treansciption factor NF-κB. We also found that enhanced glycolysis is essential for oncogene-induced cell transformation in p53-deficient cells, and propose a novel mechanism for tumor suppression by p53.

    researchmap

  • Elucidation of cell proliferation control mechanism by the new serine-threonine kinase LATS2

    Grant number:01J60030  2001 - 2002

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for JSPS Fellows  Grant-in-Aid for JSPS Fellows

    Yoshinori Abe

      More details

    Authorship:Principal investigator  Grant type:Competitive

    Grant amount:\2000000 ( Direct Cost: \2000000 )

    researchmap

▼display all